Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-12 of 12
Keywords: Immunosuppression
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
Philip Zeuschner, Stefan Ueberdiek, Alexey Pryalukhin, Christian Veith, Matthias Saar, Sigrun Smola, Rainer Maria Bohle, Kerstin Junker, Michael Stöckle, Julia Heinzelbecker
Journal:
Urologia Internationalis
Urol Int (2019) 102 (2): 238–242.
Published Online: 21 August 2018
... had a history of an immunosuppressing disease. During the 4-year follow-up, multiple relapses occurred. Thus, particularly in immunosuppressed patients, early prophylactic HPV vaccination seems to be indicated for use in the prevention of HPV-associated mutilating and life-threatening disease...
Journal Articles
Subject Area:
Further Areas
Anna Palazzetti, Andrea Bosio, Ettore Dalmasso, Paolo Destefanis, Fabrizio Fop, Francesca Pisano, Giuseppe Segoloni, Luigi Biancone, Alessandro Volpe, Antonia Di Domenico, Carlo Terrone, Samuele Iesari, Antonio Famulari, Paola Todeschini, Bruno Frea, Paolo Gontero
Journal:
Urologia Internationalis
Urol Int (2018) 100 (2): 185–192.
Published Online: 17 January 2018
... from any ideas, methods, instructions or products referred to in the content or advertisements. Renal transplant Urothelial neoplasm Bladder cancer Kidney Immunosuppression Renal transplant (RT) is the treatment of end-stage renal disease (ESRD) that provides the best quality of life...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2015) 95 (3): 367–369.
Published Online: 15 March 2014
...Matthew C. Ferroni; Benjamin T. Ristau; Stephen V. Jackman Prolonged exposure to immunosuppressive medication is a known risk factor for the development of post-transplant malignancies. De novo angiosarcoma in the post-transplant population is extremely rare. We present an 81-year-old female who...
Journal Articles
Subject Area:
Further Areas
P. Macek, M. Bodnarova, J. Zavada, P. Jezek, I. Pavlik, M. Slany, M. Havelkova, J. Stork, J. Duskova, T. Hanus, R. Kocvara
Journal:
Urologia Internationalis
Urol Int (2011) 87 (1): 120–124.
Published Online: 02 July 2011
... spread of M. marinum from hand oligoarthritis. This was initially mistaken for rheumatoid disease and methylprednisolone-induced immunosuppression led to hematogenous spread of infection to the testis and epididymis. 4 01 2011 7 04 2011 2 7 2011 © 2011 S. Karger AG, Basel 2011...
Journal Articles
M. Veroux, D. Corona, G. Giuffrida, M. Gagliano, D. Vizcarra, T. Tallarita, D. Zerbo, A. Giaquinta, M. Sorbello, M. Macarone, P. Veroux
Journal:
Urologia Internationalis
Urol Int (2010) 84 (3): 301–304.
Published Online: 13 April 2010
... and nondiabetic recipients has been reported. However, standard immunosuppressive protocols are lacking. We present our experience with sirolimus-based immunosuppression in a population of 24 type 2 diabetic patients who underwent a kidney transplantation. Patients and Methods: From January 2001 to December 2006...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1996) 57 (1): 21–26.
Published Online: 04 February 2010
... higher in the cyclosporine-treated group than in patients with conventional immunosuppression. 15 patients died within a mean survival time of 7.7 ± 12.1 months. The frequency of disorders makes it necessary for organ transplant recipients to have routine examinations both before and at regular intervals...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1992) 48 (1): 1–8.
Published Online: 03 February 2010
...S. Kleinknecht; K.-H. Bichler; W.L. Strohmaier Assessing the peripheral blood immune status, we had found evidence of immunosuppression in metastatic renal cell carcinoma. Since immunosuppression might interfere with the outcome of immunotherapy, it was submitted to further investigation...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1990) 45 (5): 269–283.
Published Online: 02 February 2010
... showed stable values during immunotherapy; neopterin, β2-microglobulin and TNF increased considerably. These findings indicate immunosuppression in patients with metastatic renal cell carcinoma, increasing with progression of the disease and possibly impairing the immunostimulating effects of biological...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1980) 35 (1): 20–23.
Published Online: 27 January 2010
...C.H. Prange; D. Bach; M. Kessler Presensitization induced by pretreatment of the recipients with donor species-specific spleen antigen cannot be completely reversed by immunosuppressive drugs. However, there is a suppressive influence of the combined administration of azathioprine and prednisolone...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1980) 35 (2): 105–111.
Published Online: 27 January 2010
.... In vivo ADLG, used as single therapy, has an immunosuppressive effect on kidney graft survival, which results in significant prolongation of mean survival time (9.6 ± 1.5 days, n = 5). 27 1 2010 Xenografting Anti-donor lymphocyte globulin Immunosuppression Graft rejection Urol. int. 35...
Journal Articles
Subject Area:
Further Areas
Massimiliano Veroux, Lidia Puzzo, Daniela Corona, Antonino Buffone, Tiziano Tallarita, Paolo Murabito, Pierfrancesco Veroux
Journal:
Urologia Internationalis
Urol Int (2007) 79 (2): 177–180.
Published Online: 13 September 2007
... of more potent immunosuppressive drug regimens has reduced the incidence of acute rejection, increasing the incidence of potentially fatal infectious complications, such as clinically important cytomegalovirus (CMV) infection. A 42-year-old kidney transplant recipient experienced on postoperative day 10...
Journal Articles
Subject Area:
Further Areas
Pierfrancesco Veroux, Massimiliano Veroux, Carmelo Puliatti, Mariachiara Valvo, Maurizio Macarone, Dario Cappello
Journal:
Urologia Internationalis
Urol Int (2003) 71 (4): 433–434.
Published Online: 28 November 2003
...Pierfrancesco Veroux; Massimiliano Veroux; Carmelo Puliatti; Mariachiara Valvo; Maurizio Macarone; Dario Cappello Two living kidney-transplant recipients under tacrolimus-based immunosuppressive therapy experienced severe neurotoxicity, with tonic-clonic seizures. In both cases the dosage reduction...